A Phase 1 Study of Intravenously Administered TR-701 FA in Subjects With Advanced Renal Impairment

Critical Care - United Kingdom
doi 10.1186/cc12641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Intravenously Administered Atrial Natriuretic Factor in Patients With COPD

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1994English

Comparison of Quality of Induction of Anaesthesia Between Intramuscularly Administered Ketamine, Intravenously Administered Ketamine and Intravenously Administered Propofol in Xylazine Premedicated Cats

Journal of the South African Veterinary Association
MedicineVeterinary
2007English

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Coronary Thrombolysis in Dogs With Intravenously Administered Human Pro- Urokinase

Circulation
Cardiovascular MedicinePhysiologyCardiology
1985English

Kinetics of Intravenously Administered Heparin in Normal Humans

Blood
BiochemistryImmunologyCell BiologyHematology
1982English

Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects With Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation
MedicinePharmacology
2014English

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy